Replies to post #27907 on Biotech Values

[DewDiligence]

> VRTX – The current valuation is $3.99 Billion. Isn't this issue a little too rich or have I missed something?<

I don’t think you’ve missed anything—the rich valuation is the reason I shorted at 39.74 (and covered at 33.69 last Wednesday). If VRTX runs hard on the heels of the EASL news, I may short it again.